First Capital Advisors Group, Llc. Codex Dna, Inc. Transaction History

First Capital Advisors Group, Llc.

  • $188 Million
  • Q2 2023

A detailed history of First Capital Advisors Group, Llc. transactions in Codex Dna, Inc. stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 307 shares of DNAY stock, worth $567. This represents 0.0% of its overall portfolio holdings.

Number of Shares
307
Holding current value
$567
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023
BUY
N/A
307 New
307 $0

Others Institutions Holding DNAY

# of Institutions
1
Shares Held
307
Call Options Held
0
Put Options Held
0
View Full List

About Codex DNA, Inc.

DNAY Quotes by TradingView
  • Ticker DNAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,518,200
  • Market Cap $54.6M
  • Description
  • Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...
More about DNAY
Track This Portfolio

Track First Capital Advisors Group, Llc. Portfolio

Follow First Capital Advisors Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Capital Advisors Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on First Capital Advisors Group, Llc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email